Spots Global Cancer Trial Database for scleroderma

Every month we try and update this database with for scleroderma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis	NCT02228850	Raynaud's Pheno...	Alprostadil Placebo	18 Years - 79 Years	NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
PatientSpot Formerly Known as ArthritisPower	NCT03840928	Rheumatoid Arth... Ankylosing Spon... Fibromyalgia Gout Crohn Disease Juvenile Idiopa... Lupus Erythemat... Myositis Osteoarthritis Osteoporosis Psoriasis Psoriatic Arthr... Scleroderma Dermatomyositis Inflammatory Bo... Polymyositis Axial Spondyloa... Diffuse Idiopat... Polymyalgia Rhe... Giant Cell Arte... Temporal Arteri... Wegener Relapsing Polyc... Undifferentiate... Spinal Cord Inj... Alzheimer Disea... Amyotrophic Lat... Ataxia Bell Palsy Brain Tumor Cerebral Aneury... Epilepsy Guillain-Barre ... Headache Head Injury Hydrocephalus Lumbar Disc Dis... Meningitis Multiple Sclero... Muscular Dystro... Neurocutaneous ... Parkinson Disea... Stroke Cluster Headach... Tension-Type He... Chronic Obstruc... Asthma Lung Cancer Cystic Fibrosis Sleep Apnea Eczema Alopecia Chronic Inflamm... Unstable Angina Heart Attack Heart Failure Arrythmia Valve Heart Dis... High Blood Pres... Congenital Hear... Peripheral Arte... Diabetes Chronic Liver D... Obesity		19 Years -	Global Healthy Living Foundation
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives	NCT05635266	Age-Related Mac... Allergies Alpha-Gal Syndr... Alzheimer Disea... Amyloidosis Ankylosing Spon... Arthritis Alopecia Areata Asthma Atopic Dermatit... Autism Autoimmune Hepa... Behcet's Diseas... Beta-Thalassemi... Cancer Celiac Disease Kidney Diseases COPD Crohn Disease Cystic Fibrosis Diabetes Dravet Syndrome DMD Fibromyalgia Graves Disease Thyroid Disease... Hepatitis Hidradenitis Su... ITP Leukemia ALS Lupus or SLE Lymphoma Multiple Sclero... Myasthenia Grav... Heart Diseases Parkinson Disea... Pemphigus Vulga... Cirrhosis Psoriasis Schizophrenia Scleroderma Sickle Cell Dis... Stroke Ulcerative Coli... Vasculitis Vitiligo	Specimen sample	18 Years - 85 Years	Sanguine Biosciences
Optical Biopsy of Human Skin in Conjunction With Laser Treatment	NCT00540566	Malignant Melan... Merkel Cell Car... Basal Cell Carc... Squamous Cell C... Atypical Nevi Congenital Nevi Seborrheic Kera... Paget's Disease Dermatofibroma Kaposi's Sarcom... Port Wine Stain Hemangioma Tattoos Scleroderma Burns	Optical Biopsy ...	18 Years - 75 Years	University of California, Irvine
Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon	NCT00378521	Raynaud's Disea... Raynaud's Disea... Raynaud's Disea...	MQX-503	18 Years - 75 Years	MediQuest Therapeutics
A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon	NCT00577304	Raynaud's Disea... Raynaud's Disea... Raynaud's Disea...	Nitroglycerin Topical AmphiMa...	15 Years - 70 Years	MediQuest Therapeutics
Pregnancy and Medically Assisted Conception in Rare Diseases	NCT02450396	Rheumatoid Arth... Spondyloarthrit... Psoriatic Arthr... Systemic Lupus ... Antiphospholipi... Sjogren Syndrom... Scleroderma Myositis Vasculitis Mastocytosis Various Autoimm...		-	Assistance Publique - Hôpitaux de Paris
A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon	NCT00577304	Raynaud's Disea... Raynaud's Disea... Raynaud's Disea...	Nitroglycerin Topical AmphiMa...	15 Years - 70 Years	MediQuest Therapeutics
Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis	NCT02228850	Raynaud's Pheno...	Alprostadil Placebo	18 Years - 79 Years	NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
Pregnancy and Medically Assisted Conception in Rare Diseases	NCT02450396	Rheumatoid Arth... Spondyloarthrit... Psoriatic Arthr... Systemic Lupus ... Antiphospholipi... Sjogren Syndrom... Scleroderma Myositis Vasculitis Mastocytosis Various Autoimm...		-	Assistance Publique - Hôpitaux de Paris
A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon	NCT00577304	Raynaud's Disea... Raynaud's Disea... Raynaud's Disea...	Nitroglycerin Topical AmphiMa...	15 Years - 70 Years	MediQuest Therapeutics

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world:

Spots Global Cancer Trial Database for scleroderma

Every month we try and update this database with for scleroderma cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for scleroderma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.